Kana Hashimoto Selected Research

Kana Hashimoto Research Topics

4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2019
2	Neoplasms (Cancer) 02/2022 - 01/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2021 - 01/2010
2	Ganglion Cysts (Ganglion) 07/2011 - 01/2011
1	Bacterial Infections (Bacterial Infection) 12/2021
1	Infections 05/2021
1	Lung Neoplasms (Lung Cancer) 05/2021
1	Shellfish Poisoning 01/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2019
1	Disease Progression 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Dementia (Dementias) 01/2017
1	Anxiety Disorders (Anxiety Disorder) 01/2017
1	Cognitive Dysfunction 01/2017
1	Mediastinal Emphysema (Pneumomediastinum) 01/2010
1	Hypoxia (Hypoxemia) 01/2010
1	Polymyositis 01/2010

2	Immune Checkpoint InhibitorsIBA 02/2022 - 05/2021
2	NivolumabIBA 05/2021 - 01/2019
2	Pheromones (Semiochemicals)IBA 07/2011 - 01/2011
2	Neurotransmitter Agents (Neurotransmitter)IBA 07/2011 - 01/2011
2	Peptides (Polypeptides)IBA 07/2011 - 01/2011
2	NeuropeptidesIBA 07/2011 - 01/2011
1	Tyrosine Kinase InhibitorsIBA 02/2022
1	AgarIBA 12/2021
1	CreatinineIBA 05/2021
1	durvalumabIBA 05/2021
1	Okadaic AcidIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019
1	Bevacizumab (Avastin)FDA Link 10/2019
1	ErbB Receptors (EGF Receptor)IBA 10/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2017
1	hachimijiogan (TJ 7)IBA 01/2017
1	Nerve Growth Factor (NGF)IBA 01/2017
1	AcidsIBA 07/2011
1	Sex AttractantsIBA 01/2011
1	MyoglobinIBA 01/2010
1	EnzymesIBA 01/2010
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2010
1	Jo-1 antibodyIBA 01/2010
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2010